What is Bio-Techne's free cash flow?

Bio-Techne (TECH) reported free cash flow of $77.58M in Q1 2026.

How has Bio-Techne's free cash flow changed year-over-year?

Bio-Techne's free cash flow increased by 150.3% year-over-year, from $31M to $77.58M.

What is the long-term trend for Bio-Techne's free cash flow?

Over 4 years (2021 to 2025), Bio-Techne's free cash flow has grown at a -4.5% compound annual growth rate (CAGR), from $307.86M to $256.55M.

Bio-Techne TECH Free cash flow

Free cash flow at other companies

Thermo Fisher ScientificTMO

$816M+126%

DanaherDHR

$1.09B+2.9%

Agilent TechnologiesA

$201M+87.9%

BrukerBRKR

——

RevvityRVTY

——

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Calculated from Bio-Techne’s reported figures.

$86.7Mnet cash from operating−$9.1Mcapital expenditures=$77.58M

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Techne's free cash flow?: Bio-Techne (TECH) reported free cash flow of $77.58M in Q1 2026.
How has Bio-Techne's free cash flow changed year-over-year?: Bio-Techne's free cash flow increased by 150.3% year-over-year, from $31M to $77.58M.
What is the long-term trend for Bio-Techne's free cash flow?: Over 4 years (2021 to 2025), Bio-Techne's free cash flow has grown at a -4.5% compound annual growth rate (CAGR), from $307.86M to $256.55M.